Adient Cut to Equal-Weight From Overweight by Wells Fargo
Adient Analyst Ratings
Wells Fargo Downgrades Adient(ADNT.US) to Hold Rating, Cuts Target Price to $20
Morgan Stanley Maintains Adient(ADNT.US) With Sell Rating, Maintains Target Price $19
Morgan Stanley Reaffirms Their Sell Rating on Adient (ADNT)
Adient Cut to Neutral From Buy by B of A Securities
BofA Securities Downgrades Adient(ADNT.US) to Hold Rating, Cuts Target Price to $24
Adient Is Maintained at Underweight by Morgan Stanley
Adient Analyst Ratings
Morgan Stanley Maintains Adient(ADNT.US) With Sell Rating, Cuts Target Price to $19
Barclays Maintains Adient(ADNT.US) With Hold Rating, Maintains Target Price $24
Barclays Keeps Their Hold Rating on Adient (ADNT)
Barclays Maintains Adient(ADNT.US) With Hold Rating, Maintains Target Price $24
Adient (ADNT) Gets a Hold From Barclays
Adient Is Maintained at Buy by B of A Securities
Adient Analyst Ratings
BofA Securities Maintains Adient(ADNT.US) With Buy Rating, Cuts Target Price to $30
Wells Fargo Maintains Adient(ADNT.US) With Buy Rating, Maintains Target Price $27
Morgan Stanley Maintains Adient(ADNT.US) With Sell Rating, Maintains Target Price $21
Adient Is Maintained at Overweight by Wells Fargo